Pharmacokinetics of Ciprofloxacin with Reference to Other Fluorinated Quinolones
- 1 February 1989
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 1 (1) , 10-17
- https://doi.org/10.1080/1120009x.1989.11738857
Abstract
The third generation quinolones, ciprofloxacin, enoxacin, fleroxacin, norfloxacin, ofloxacin and pefloxacin are all quickly and quantitatively well (75 - 95% of an oral dose) absorbed upon oral administration. The maximum serum concentrations appear after 1 - 2 hours. The serum and urine concentrations after oral or intravenous ciprofloxacin are direcdy proportional with the doses and follow normal, dose-independent pharmacokinetics. Ciprofloxacin and norfloxacin reach the same serum levels after the same doses. Steady-state levels are indifferent from those after the first dose. In contrast, enoxacin, oflaxacin and pefloxacin do reach somewhat higher levels after chronic administration. Ciprofloxacin is eliminated by the kidneys (active tubular secretion which is blocked by probenecid) (60% after an intravenous administration), by metabolism and by the transintestinal route. Metabolism is minimal (ca. 15-20% for ciprofloxacin and norfloxacin). Transintestinal elimination implies that the drug is eliminated by transport across the intestinal wall without significant biliary elimination (which is less than 1%). Penetration into tissues occurs readily. Concentrations in prostate secretion are high for ciprofloxacin and norfloxacin. Ciprofloxacin reaches high intracellular concentrations; within human neutrophils the levels reach 6 times the concentrations in the surrounding fluid. Concentrations in bile and tissues are in general comparable to those in serum. Cerebrospinal fluid (CSF) concentrations are low when meningi are nomai, but 40-90% of the serum levels when the meninges are inflamed. Because the transintestinal route of elimination compensates for loss of renal elimination, the serum half-life of ciprofloxacvin is raised only to 5 - 10 hours even in total renal failure. Norfloxacin behaves similarly in patients with terminally reduced renal functions, whereas ofloxacin shows increased half-life starting from a creatinine clearance of ca. 30 ml/min; in terminal renal function ofloxacin half-life values are up to 40-50 hours.Keywords
This publication has 57 references indexed in Scilit:
- Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal functionAntimicrobial Agents and Chemotherapy, 1987
- Absolute oral bioavailability of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1986
- Dose ranging study and constant infusion evaluation of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1986
- Pharmacokinetics of ciprofloxacin after intravenous and increasing oral dosesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microfloraAntimicrobial Agents and Chemotherapy, 1986
- Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral dosesAntimicrobial Agents and Chemotherapy, 1986
- The Pharmacokinetics and Serum and Urine Bactericidal Activity of CiprofloxacinThe Journal of Clinical Pharmacology, 1985
- Pharmacokinetics of ciprofloxacin after oral and parenteral administrationAntimicrobial Agents and Chemotherapy, 1985
- Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteersAntimicrobial Agents and Chemotherapy, 1984
- Dose- and sex-independent disposition of ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984